论文部分内容阅读
本品系由尖吻蝮(Agkislrodon aculus)蛇毒中提取的一种蛇毒酶制剂。是一种糖蛋白,由17种氨基酸、263个残基组成,是中国科学院昆明动物研究所创制的抗凝新药,其注射液为无色澄明液体。经20多个医院试用于闭塞性血管性疾病,结果取得显著疗效,具有明显的去纤、溶纤作用,于昆明市通过了技术鉴定。药理作用:药理研究结果表明,本品使血浆纤维蛋白元含量显著降低,从而导致血液粘度、血小板、红细胞聚集性下降。体内试验,本品可使正常人或家犬、家兔血清蛋白含量及血液粘度显著降低,使全血凝固、凝血酶元时间等显著延长,但对其它凝血因子和血小板计
The strain is a snake venom enzyme preparation extracted from Agkistrodon aculus snake venom. Is a glycoprotein consisting of 17 amino acids and 263 residues. It is a new anticoagulant drug invented by Kunming Institute of Zoology, Chinese Academy of Sciences. Its injection is colorless and clear liquid. After more than 20 hospitals in the trial of occlusive vascular disease, the results achieved significant efficacy, with significant defibrillation, fibrinolytic effect, passed the technical appraisal in Kunming. Pharmacological effects: pharmacological studies have shown that this product significantly reduces plasma fibrinogen, resulting in decreased blood viscosity, platelets, erythrocyte aggregation. In vivo test, this product can make normal people or dogs, rabbit serum protein content and blood viscosity was significantly reduced, the whole blood coagulation, thrombin time significantly prolonged, but other coagulation factors and platelet